Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. It also provides disease-modifying therapeutic agents; genetically modified pigs for regenerative medicine applications; proprietary methane bioconversion platform that converts natural gas into energy and chemicals; and reproductive and embryo transfer technologies. In addition, the company offers the UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components in complex gene expression programs; mbIL15, a gene that improves the functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite Recombinases, that breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of genetically modified adenovector serotypes; and L. lactis is a food grade bacterium. In addition, it provides an inducible genetic switch RheoSwitch that provides dose-proportional quantitative regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; UltraCAR-T platform for cancer treatment; AdenoVerse Immunotherapy, a library of proprietary adenovectors for gene delivery; and the ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides to the mucosa. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading SA; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Fibrocell Science, Inc.; OvaXon, LLC; S&I Ophthalmic, LLC; Harvest newly created entities; and Surterra Holdings, Inc. The company was previously known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.
How to buy Precigen (PGEN) shares. step by step in spanish
Do you want to learn how to acquire Precigen (PGEN) shares on Nasdaq in Spain and through an officially regulated broker? Are you interested in being able to invest your profits from the piggy bank and make profits on the stock market? Here I am going to show you how easy it is to create an account in Degiro , a regulated investment platform and minimum commissions, and how you will be able to get your first shares of the company Precigen, Inc. (PGEN) (PGEN) from quick and easy way.
The method is very simple :
- The first step is that we will register a debit account, interface where we will invest in the shares of Precigen, Inc. (PGEN) – (PGEN).
- Then we will enter euros to then carry out our first investment in Degiro.
- When we see the funds in our account, we must locate Precigen using its ticker, which is PGEN.
- To finish, we are only going to indicate the number of shares that we are going to obtain, price and type of order.
Perhaps the tutorial has been a little bit detailed for you, so we are going to see the entire procedure with images.
Tutorial, register an account in DEGIRO.
First of all we must register in DEGIRO at the following link :
It will ask us for an email, a username and a password to have access, and later we will continue through the link that they have sent us by email.
Soon Degiro will require some essential data to validate our identification card . We need to have our passport number, DNI (identity document) or driving license, your cell phone and the bank account number that we are going to use to make our first deposit. If you have no idea what method this format is, you can review this simple guide article that we have created at Educacep .
Once our account is credited we can put money from the Enter / Withdraw option. We have the possibility of making a transaction that will take between two to three days, or carry out the deposit instantly using Sofort, a totally secure and very reliable payment gateway.
How to buy Precigen (PGEN) shares through Degiro
When we have the money we can invest in our 1st action. You can select the place order button in the upper right corner or use the Degiro search engine and type the ticker. In the following screenshot you will see that I have used the Amazon ticker but you should insert (PGEN), the Precigen ticker. As we are talking about an action, we will notice that the related tickers are listed and there we will discover to find Precigen. What is key is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Precigen, Inc. (PGEN) is listed on Nasdaq. This step is very fundamental so make no mistake.
When developing the order we must pay close attention to what I am going to explain to you now . We can place a limit or market order. Think you want to buy a share of Precigen at 6.62, but its price today is quite prominent. With a limit order we will place the value at which we plan to execute the operation and until there are no shares selling at that price, the purchase of the share will not be executed. With a market order, you will buy the number of shares that we have proposed at today’s sale price, which will be closely related to the live listing price.
In any situation it is very important that you look at the type of alignment: permanent or day . To give an example, in Spain, the stock market is in the morning until 1 in the afternoon, and in the US it corresponds to the afternoon hours of Spain. If an order is fixed, it will continue until the point where it can be executed, but if you opt for the “of the day” option, at the end of that day, if it has not been executed, it will be removed from your Activity panel – Orders in pending status.
I hope this simple tutorial will help you to buy shares in Precigen. Until next time!
|Name||Title||Payment||exercised||Year of birth|
|Mr. Randal J. Kirk||Executive President||N/A||N/A||1953|
|Dr. Helen Sabzevari MPH, Ph.D.||President, CEO and Director||1.77 million||N/A||1962|
|Mr. Donald P. Lehr||Legal Director and Sec. Corp.||808.21k||N/A||1975|
|Mr. Jeffrey Thomas Perez||Senior Vice President of Intellectual Property Affairs||705.72k||N/A||1972|
|Dr Thomas D Reed||Founder and scientific director||N/A||N/A||1966|
|Mr. D. Bradford Osborne||VP Finance & Accounting and Chief Accountant||N/A||N/A||1980|
|Mr. Rutul R. Shah||Head of Operations and Portfolio||N/A||N/A||N/A|
|Mr Steven Harasym||Head of Investor Relations||N/A||N/A||N/A|
|marie rossi||Vice President of Communications||N/A||N/A||N/A|
|Mr Rob Russell||Head of human resources||N/A||N/A||N/A|
Recent Precigen Events:
No events registered in Educacep